talcum powder ovarian cancer, johnson and johnson baby powder lawsuit, baltimore product liability attorneys, talcum powder lawsuit attorneys, baby powder cancer lawsuit, johnson and johnson lawsuit, ovarian cancer lawsuit

The Yost Legal Group Launches new TV commercial Educating Women About the Link Between Talcum Powder Use & Ovarian Cancer

June 14th, 2016

Johnson & Johnson failed to warn women for years about the serious health risks associated with long-term use of talcum powder. Research shows that potentially thousands of women that regularly used Johnson & Johnson talcum powder products were at an increased risk of developing ovarian cancer.

Despite the known link between talcum powder and ovarian cancer, J&J continued to sell products such as Johnson’s Baby Powder® and Shower to Shower® without warning labels.

As of May 2016, there are over 1,200 pending lawsuits against J&J regarding the link between ovarian cancer and talcum powder. Johnson & Johnson has already been ordered to pay $127 million in damages from two lawsuits that were won by two women that developed ovarian cancer as a result of long-term talcum powder use.

If you or a loved one regularly used Johnson & Johnson talcum powder products for feminine hygiene purposes and were diagnosed with ovarian cancer, you may be eligible to file a claim.

Call The Yost Legal Group at 1-800-YOST-LAW (967-8529) for a FREE, confidential consultation.

Watch our brand new television commercial below to learn more and to find out how the dedicated, experienced attorneys of The Yost Legal Group may be able to help.

Staying Up To Date: Talcum Powder

A Multi-District Litigation (MDL) has been ordered to combine Johnson & Johnson talcum powder lawsuits from federal courts all over the country into one court, the U. S. District Court of New Jersey. All federal cases citing the use of Johnson & Johnson talcum powder as the cause of ovarian cancer can now be filed directly into the MDL. This MDL was formed to speed up the handling of more than 2,000 talcum powder-related suits…

Read More »

Third Verdict in Johnson & Johnson Talcum Powder Trial Resulting in $70 Million maryland talcum powder law firm, baltimore talc powder attorneys, baltimore product liability lawyers, maryland product liability attorneys, washington d.c talcum powder law firm, washington d.c product liability attorneys, talcum powder lawsuit, johnson and johnson talcum powder lawsuit, talcum powder verdict

A Saint Louis jury recently awarded a 62-year-old California woman over $70 million dollars in damages. The women claimed her long-term regular use of Johnson & Johnson Talcum Powder caused her ovarian cancer. The California women had religiously used J & J Talcum Powder for over 40 years for feminine hygiene. She immediately stopped using this product after her diagnosis of ovarian cancer three years ago. The women has undergone surgery, radiation and chemotherapy to…

Read More »

California Woman Sues Johnson & Johnson, Claims Company Failed to Warn that Talcum Powder Products May be Linked to Ovarian Cancer talcum powder ovarian cancer, johnson and johnson lawsuit, talcum powder lawsuit attorneys, ovarian cancer, baltimore product liability lawyers, baltimore product liability law firm

Thousands of pending lawsuits against Johnson & Johnson allege that the company failed to warn their customers about the potential link between regular use of talcum powder for feminine hygiene purposes and an increased risk of developing ovarian cancer. The most recent talcum powder ovarian cancer case against Johnson & Johnson began this week in St. Louis, MO. The Plaintiff in this case is a California woman that was diagnosed with ovarian cancer in 2012….

Read More »

FDA Recommends Against Ovarian Cancer Screening Tests ovarian cancer, ovarian cancer awareness month, fda safety warning, ovarian cancer screening, baltimore injury lawyers, baltimore medical mistake attorneys, cancer awareness

The FDA is alerting women about the risks associated with the use of tests being marketed as ovarian cancer screening tests. The FDA warns that these tests may result in “false-negatives” in women that are at high risk for ovarian cancer, thereby discouraging them from seeking the immediate medical treatment they need. Ovarian cancer is the fifth leading cause of cancer related deaths among women in the U.S. and results in an estimated 15,000 deaths…

Read More »